Cysteamine vs Zinc Oxide

Cysteamine: Can reduce melasma pigmentation in tested topical formulas. Zinc Oxide: Provides UV protection in tested sunscreens and wetness protection in barrier creams.

Research updated 2026-10-25
Four cysteamine products: a Senté tube, an Omic+ cream and box, a 5% cysteamine serum dropper and a Cyspera bottleFour mineral sunscreens on white: Native SPF 30, Thinksport SPF 50, Colorescience Flex and EltaMD UV Clear

Which one is right for you?

Choose Cysteamine if…

Consider for diagnosed melasma when a suitable topical option is needed.

  • Diagnosed melasma
  • Hydroquinone isn’t suitable
  • You can follow short-contact wash-off

Choose Zinc Oxide if…

Choose a broad-spectrum sunscreen you will use consistently, or a labelled barrier paste for wetness.

  • Sensitive skin or melasma
  • Broad UVA and UVB protection
  • Diaper or friction areas
Often combined

Can you use both?

Daily sunscreen is essential when using cysteamine for pigment.

At a glance

● Cysteamine
● Zinc Oxide
Type
Pigment-targeting active
Mineral UV filter and skin protectant
What it does
Can reduce melasma pigmentation in tested topical formulas.
Provides UV protection in tested sunscreens and wetness protection in barrier creams.
Best for
Melasma
Sunburn; Diaper Rash; Melasma; Wrinkles and Fine Lines
Studied concentrations
5% cream in controlled melasma trials; contact instructions vary by product.
Use a tested sunscreen by its broad-spectrum SPF; barrier pastes are different products.
When to use
On the schedule specified for the product or prescribed treatment.
Each morning and before sun exposure.
Time to results
Usually assessed over 8–16 weeks
Protection with correct application; prevention continues over time
Irritation
Odour, stinging and irritation may limit use; follow wash-off instructions.
May leave a white cast or feel heavy; other formula ingredients can irritate.
Sensitive skin
Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.
Choose a simple formula and test a small area first. Individual tolerance matters more than an ingredient’s reputation for being gentle.
Available
Prescription or cosmetic status depends on the active, formula and country; check the label.
Prescription or cosmetic status depends on the active, formula and country; check the label.

What it helps

Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.

Evidence level
Cysteamine
Zinc Oxide
Strong evidenceMost established uses
—
Sunburn: 1. Sunburn Header — Light Skin; Lighter skin.

Sunburn

A correctly used tested sunscreen helps prevent UV sunburn.
Moderate evidenceSome supportive research
Flat tan patches with soft irregular edges across the forehead and upper cheek of an adult with light skin, the surface completely smooth.

Melasma

A placebo-controlled trial found reduced pigmentation with 5% cream.
Flat tan patches with soft irregular edges across the forehead and upper cheek of an adult with light skin, the surface completely smooth.

Melasma

Sun protection supports melasma care; tinted formulas may add visible-light protection.
Diaper Rash, close-up of representative skin findings.

Diaper Rash

Labelled zinc-oxide pastes protect skin from wetness and friction.
A relaxed forehead with faint shallow horizontal fine lines.

Wrinkles and Fine Lines

Regular sunscreen helps prevent further photoaging rather than erase existing folds.
Insufficient evidence
Flat light-brown residual marks on a fair cheek.

Post-Inflammatory Hyperpigmentation

The cited melasma trial does not establish fading of every type of dark mark.
The front of a forearm on fair skin. Two pale patches with sharp edges sit against lightly tanned skin, and the difference between the patch and the skin around it is subtle.

Vitiligo

The reviewed sources do not establish this ingredient as a treatment for this concern.
Sensitive Skin on light skin.

Sensitive Skin

The reviewed sources do not establish this ingredient as a treatment for this concern.
Redness and fine superficial vessels across a light-skinned cheek and nose.

Rosacea

The reviewed sources do not establish this ingredient as a treatment for this concern.
Inflamed acne on light skin. The spots sit in a patch of pink, and the ring of redness around each one is easy to see. A few have a yellow-white head, and the skin between them is dry and flaking.

Acne

The reviewed sources do not establish this ingredient as a treatment for this concern.
How it works

Cysteamine

Cysteamine mechanism diagram. Affects melanin formation: Cysteamine acts through several pigment pathways. May help melasma: The formula, contact time and tolerance matter.
Open full-size diagram
Diagram explanation and sources

Affects melanin formation: Cysteamine acts through several pigment pathways. May help melasma: The formula, contact time and tolerance matter.

Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.

Source 1

Zinc Oxide

Zinc Oxide mechanism diagram. Absorbs and scatters UV: Particles act in a film at the skin surface. The full sunscreen matters: Broad-spectrum protection depends on the formula.
Open full-size diagram
Diagram explanation and sources

Absorbs and scatters UV: Particles act in a film at the skin surface. The full sunscreen matters: Broad-spectrum protection depends on the formula.

Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.

Source 1 · Source 2 · Source 3 · Source 4

Using both in one routine

Built from where each one usually sits in a routine. Introduce one at a time.

Morning
Step 1
Cleanser
Step 2
Moisturizer
Step 3
Zinc OxideMorning
Night
Step 1
Cleanser
Step 2
CysteamineNight
Step 3
Moisturizer

Strengths and forms

Concentrations

5% cysteamine cream is the main concentration studied for melasma. Contact time is product-specific; some studied formulas are short-contact treatments rather than overnight creams.

5%

Studied melasma cream

Controlled trials studied this strength. One short-contact trial used a specific cream; follow the current product’s instructions rather than copying a study schedule.

Choosing a strength: Choose a finished topical product with clear instructions for how long to leave it on and when to rinse.

Higher strengths: There is no established benefit from escalating beyond the studied strength. Burning, redness or a persistent rash are reasons to stop and reassess.

Formula matters: Stabilization, the base cream and exposure time affect tolerability. Different cysteamine formulations need not have identical instructions.

Zinc oxide sunscreen and thick barrier ointment have different jobs. U.S. sunscreen concentrations can be up to 25%; some skin-protectant ointments use more than 25% through 40%.

25%

25–40%

U.S. sunscreen ceiling

The permitted upper concentration is not an SPF rating. Choose a finished sunscreen by its tested protection.

Higher skin-protectant ointments

The monograph specifies more than 25% through 40% in ointments. These barrier products are not automatically sunscreens.

Choosing a strength: For sun protection, choose a tested broad-spectrum sunscreen with appropriate SPF. For a barrier ointment, choose its labeled protective purpose.

Higher strengths: More zinc oxide alone does not prove higher SPF, better UVA coverage or a better diaper-rash result.

Formula matters: Particle characteristics, dispersion and the full formula affect protection and feel. An unlabeled zinc paste should not be substituted for sunscreen.

Forms
Cream
Sunscreen · Tinted sunscreen · Barrier paste

When you’ll see results

Approximate windows, not promises.

● Cysteamine
● Zinc Oxide
First few weeks

First few weeksAssess tolerance first; pigment change is usually slower.

First few weeksProtection starts with correct application; it does not require a weeks-long course.

4–8 weeks

4–8 weeksSome studied regimens begin showing pigment improvement.

4–8 weeksConsistency matters; this is prevention, not a spot-clearing treatment.

8–12 weeks

8–12 weeksA useful review point for benefit and irritation.

8–12 weeksContinue correct application and reapplication.

3–6 months

3–6 monthsMany melasma trials assess results over three to four months; recurrence is common.

3–6 monthsMonitor tolerance and sun exposure; a changing spot needs assessment.

6–12 months

6–12 monthsLong-term use depends on the active; follow a monitored plan rather than extending treatment automatically.

6–12 monthsPhotoaging prevention is a long-term benefit, not a promise of wrinkle reversal.

Safety and sensitive skin

Common reactions

Odour, stinging and irritation may limit use; follow wash-off instructions.

May leave a white cast or feel heavy; other formula ingredients can irritate.

When to stop

Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.

Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.

Sensitive or inflamed skin

Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.

Choose a simple formula and test a small area first. Individual tolerance matters more than an ingredient’s reputation for being gentle.

Important limits

Do not use a cosmetic product as a substitute for diagnosis of an unexplained, changing or persistent skin problem.

Do not use a cosmetic product as a substitute for diagnosis of an unexplained, changing or persistent skin problem.

Pregnancy

Data in pregnancy are limited; ask the clinician managing your pregnancy before using.

Mineral sunscreens are generally considered acceptable in pregnancy.

How it works

In the skin

On the skin. The finished product delivers cysteamine in a particular vehicle.

Entering skin. Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.

Conversion. No activation step is established as necessary for its intended topical role.

Skin response. Acts on pigment-related pathways; the cream, contact time and tolerance influence its practical effect.

Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.

On the skin. The finished product delivers zinc oxide in a particular vehicle.

Entering skin. Formula-unit mass is not particle size. These mineral particles act in the surface sunscreen film; the 500 Da guideline does not predict particle penetration.

Conversion. No activation step is established as necessary for its intended topical role.

Skin response. Particles absorb and scatter UV at or near the surface; barrier pastes also shield skin from moisture and friction.

Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.

Getting in
Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.
Formula-unit mass is not particle size. These mineral particles act in the surface sunscreen film; the 500 Da guideline does not predict particle penetration.
Molecule size
Cysteamine · 77 Da
Zinc Oxide · 81 Da
Smaller than 500 Da passes the outer skin more easily. Size isn’t an effectiveness score.
500 Da guideline

Common questions

Cysteamine:What should I choose cysteamine for?

Consider for diagnosed melasma when a suitable topical option is needed.

Cysteamine:How strong is the evidence?

A small placebo-controlled study supports 5% cream over four months. Active-comparator studies are small and do not prove equal efficacy to hydroquinone. The mass shown refers to the free base, not its hydrochloride salt.

Zinc Oxide:What should I choose zinc oxide for?

Choose a broad-spectrum sunscreen you will use consistently, or a labelled barrier paste for wetness.

Zinc Oxide:How strong is the evidence?

Sun protection is established for tested sunscreen products, not loose zinc powder. Formula-unit mass is not particle size. A sunscreen ageing trial cannot isolate zinc oxide or prove reversal of existing wrinkles.

Sources

Sources and further reading

  1. Evaluation of the efficacy of cysteamine 5% cream in the treatment of epidermal melasma: a randomized double-blind placebo-controlled trial. (2015)
  2. Sunscreen and prevention of skin aging: a randomized trial. (2013)
  3. Support for the Safe Use of Zinc Oxide Nanoparticle Sunscreens: Lack of Skin Penetration or Cellular Toxicity after Repeated Application in Volunteers. (2019)
  4. Near-visible light and UV photoprotection in the treatment of melasma: a double-blind randomized trial. (2014)
  5. FDA skin-protectant monograph
  6. FDA sunscreen application guidance
  7. Short-contact 5% cysteamine clinical trial
  8. FDA sunscreen monograph M020: permitted concentrations
  9. FDA sunscreen regulatory updates, including 2026 orders
Dermapedia on YouTube